Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Will Russia have a tuberculosis vaccine?

17.03.2008
Specialists of the State Research Center for Virology and Biotechnology “Vector” have tested on mice a new experimental preparation for tuberculosis vaccinal prevention (it cannot be called a vaccine yet, as it has not received all required verifications and approvals). The preparation is nontoxic and does not provoke the animals’ immune response.

Tuberculosis that takes away lives of two million people remains a very dangerous disease. Physicians all over the world are working to produce efficient tuberculosis vaccines, but their effort has not succeeded yet. All preparations available do not ensure complete protection from the disease.

For example, efficiency of one of the most widespread vaccines – BCG – varies from 80% to 0%. The experimental vaccine, the Novosibirsk researchers are working at, is a DNA fragment that codes the ESAT-6 mycobacterial antigen. Production of such a vaccine became possible after thorough investigation of genomes of mycobacteria – causative agent of tuberculosis – and of a congener bacterium - Mycobacterium bovis.

The majority of existing tuberculosis vaccines represent weakened mycobacteria cultures: a vaccine is supposed to provoke the immune response, but not the disease. The bacteria are weakened by removing from them the genes that are responsible for virulent properties, including the gene that codes the ESAT-6. It is absent from all existing Mycobacterium bovis BCG vaccine cultures. The Novosibirsk researchers staked specifically on this protein, which should not pose danger by itself .

Having established a proper genetically engineered construction, the researchers surrounded it by a polysacharide covering of polyglucin and spermidine. The covering reliably protects the DNA from enzymes that can destroy it. In the organism, polyglucin gradually decomposes, and the DNA becomes accessible to the immune system cells. The mice were immunized by the obtained preparation for three times. The preparation was injected intramuscularly at a two-week interval. The reference group animals were immunized by polysaccharides and the DNA, which did not contain the vaccine gene.

After vaccination, the mice were observed for 10 more days, and during this period, they did not lose weight and did not show any other symptoms of health impairment. Nevertheless, the animals had to be slaughtered to investigate their immune system reaction. Vaccines should stimulate cell-mediated immunity, and indeed, lymphocyte clones were formed with mice after immunization. The lymphocyte clones started to divide actively in response to introduction of the real ESAT-6 protein, at that the reaction significantly exceeded the background reaction. As for the reference group mice, their lymphocytes did not react to the protein injection. The analysis has proved that specific cell-mediated immunity was formed with vaccinated mice.

This is not a vaccine yet, it is only the first step to its development. As a matter of fact, the step has been successful.

Olga Myznikova | alfa
Further information:
http://www.informnauka.ru

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

Quantum optical sensor for the first time tested in space – with a laser system from Berlin

23.01.2017 | Physics and Astronomy

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>